Lilly’s GLP-1 medications will soon be covered by CVS, potentially opening access for millions of Americans

Published May 28, 2026 · Category: 金融投资

Overview

That means millions more Americans may get access to Lilly’s new GLP-1 pill Foundayo or the GLP-1 injection Zepbound.

Source

Originally published at www.marketwatch.com.

Related Articles

• Investors would be crazy to turn bearish on stocks now, says veteran strategist. In six months, maybe not.
• Oil prices climb for a third straight day as peace-deal hopes teeter
• OECD gives a stark warning while lowering 2027 growth forecasts